HMGB1 and central nervous system cancer: Moreover, the upregulation of high-mobility group box 1 protein (HMGB1) was reported to weaken the inhibition of glioma growth caused by the knockdown of LINC00662, suggesting that HMGB1 should be considered an miR-107 target.